Resmed results showed a revenue increase of 11% to $1.4 billion. Income from operations increased 18%. 

It is not uncommon for DME suppliers and sleep labs to work together in the provision of therapeutic equipment to patients who test positive for OSA.

Company officials attributed a 3Q revenue jump to continued higher demand from international and domestic business-to-business customers.

Results for quarter ended Sept. 30, 2025 from Medtrade exhibitor Resmed Inc. showed a 9% revenue increase.

CAIRE’s award-winning FreeStyle Comfort portable oxygen concentrator with proprietary autoSAT technology is now available in the United States.

Medtrade exhibitor Resmed recently launched the Sleep Institute, a global clinical insights initiative.